Chad Gassert - 22 Jun 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Signature
/s/ Chad Gassert, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
22 Jun 2023
Transactions value $
-$1,026,400
Form type
4
Filing time
23 Jun 2023, 20:00:34 UTC
Previous filing
04 Apr 2023
Next filing
06 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$1.03M -20K -5.09% $51.32 373K 22 Jun 2023 Held by Chali Properties LLC F1, F2
holding ANIP Common Stock 28.9K 22 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
F2 The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.